Rostock International Parkinson's Disease Study (ROPAD)

Completed

Conditions studied: Parkinson´s Disease

In brief

Rostock International Parkinson's Disease Study - An International, multicenter, epidemiological observational study aiming at identification of LRRK2-positive patients, the recruitment of 25,000 PD participants and the establishment of a candidate biomarker in the LRRK2-positive cohort.

Key facts

Study ID
NCT03866603
Run by
CENTOGENE GmbH Rostock
People needed
20112
Starts
2019-05-30
Expected to finish
2024-10-10
Last updated by the study team
2026-04-13

Who can join

Age: 30 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.